Rapidly Expanding Field of Gene Therapy $NTLA

Длинная

Intellia Therapeutics, Inc. (NASDAQ:NTLA)

Обновлено

NASDAQ:NTLA Intellia Therapeutics, Inc.

indicator chartpattern genetherapy biopharma

I have know about this stock for over a year now, but I have never put the time into charting it. The time is near to buy in, and the patient investor will wait for the MACD to bottom out then buy.

Комментарий:

There has been some slight turbulence in the markets as of late, but to maintain trend lines is key. I did buy in @$21.40 and as long as the price continues to stay above my trend lines I will not sell a share.

Отказ от ответственности

Все виды контента, которые вы можете увидеть на TradingView, не являются финансовыми, инвестиционными, торговыми или любыми другими рекомендациями. Мы не предоставляем советы по покупке и продаже активов. Подробнее — в Условиях использования TradingView.